Objective To determine prognostic factors that independently predict response to antimicrobial therapy in children with acute sinusitis.
Conclusions
In children with acute sinusitis, proven nasopharyngeal colonization with S pneumoniae at presentation independently predicted time to symptom resolution. Future randomized, placebo-controlled trials could investigate the usefulness of testing for the presence of nasopharyngeal pathogens as a predictor of response to treatment.
(J Pediatr 2014;-:---).
K nowledge of prognostic factors that may predict duration of symptoms in children treated for presumed acute bacterial sinusitis would allow physicians to counsel parents appropriately regarding the expected course of illness. In addition, if strong predictive factors are identified, these factors could be used as stratification variables in future clinical trials. This would allow researchers to ensure that groups are comparable with respect to known affecting outcome factors. 1 In adults with acute sinusitis, age, 2 clinical severity, 2 and growth of pathogenic bacteria from nasopharyngeal culture 3 appear to be helpful in predicting the response to therapy. No published studies to date have investigated which factors predict resolution of symptoms in children with acute sinusitis. The objective of this study was to identify factors that independently predict response to antimicrobial therapy in children with acute sinusitis.
Methods
We prospectively enrolled consecutive children 2-12 years of age with clinically diagnosed acute sinusitis presenting to 1 of 6 general ambulatory pediatric clinics in Pittsburgh during 2 consecutive respiratory seasons. Most (90%) children were enrolled during the winter months (October to March of 2008-2009 and 2009-2010) . The diagnosis of acute sinusitis was made according to stringently defined a priori clinical criteria consistent with the American Academy of Pediatrics most recent guidelines. 4 Children with: (1) persistent upper respiratory tract symptoms (ie, 10-29 days of cough [not exclusively nocturnal] and/or nasal symptoms [rhinorrhea of any quality]) who were not improving; or (2) worsening symptoms (substantial worsening of nasal symptoms and/or fever after a period of improvement) were eligible. We excluded children who: (1) had received antimicrobial treatment within 7 days before presentation; (2) had evidence of another infection (ie, acute otitis media or pneumonia); or (3) had underlying immune deficiency, cystic fibrosis, ciliary dyskinesis, or major developmental delay. We excluded children who met clinical criteria for sinusitis for whom antimicrobial agents were not prescribed by their primary care physician because of the mild nature of their illness. Children with asthma who were otherwise eligible were
Supported by National Institute of Health (UL1 RR024153, University of Pittsburgh CTSI). N.S. was supported by National Institute of Health (1R21AI076677). The authors declare no conflicts of interest. included only if they were not wheezing at examination and if they had nasal symptoms that were worsening or persistent (ie, no child with asthma was enrolled on the basis of prolonged cough alone). Children with a history of allergic rhinitis who met the entry criteria were included only if their respiratory symptoms had worsened acutely. This study was conducted 8-10 years after the 7-valent pneumococcal conjugate vaccination (PCV7) was introduced but was completed before introduction of the 13-valent pneumococcal conjugate vaccination (PCV13). The Institutional Review Board at the University of Pittsburgh approved this study before patient enrollment. At the time of diagnosis, one of the study investigators interviewed parents regarding their child's symptoms and performed a detailed physical examination. The same investigator also obtained a nasopharyngeal specimen at the baseline visit by using a sterile, flexible, thin, polyester/ rayon-tipped moistened swab. In some cases, a nasopharyngeal culture was not performed (mostly as the result of parental refusal). The swab was placed into Amies transport media (without charcoal), refrigerated, transported to the laboratory for culturing, and inoculated onto a trypticase soy 5% sheep blood agar and a chocolate plate. Cultures were incubated overnight at 37 C with 5% CO 2 . If no growth was present after overnight incubation, the culture was reincubated for another 24 hours. Growth of pathogenic bacteria (Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis) was assessed by the use of standard semiquantitative techniques (growth in 0, 1, 2, 3, or 4 quadrants); 3+ and 4+ growth was considered heavy growth. Pneumococcal isolates that were resistant to oxacillin by disk diffusion were further tested with an E-test to determine their minimum inhibitory concentration (MIC) to penicillin. Isolates for which the penicillin MIC was between 0.1 and 1 mg/mL were defined as penicillin intermediate, and those for which the penicillin MIC was >1 mg/mL were defined as penicillin resistant. The decision to begin antimicrobial therapy and the agent used was at the discretion of the treating clinician. In all cases, the nasopharyngeal swab was collected before therapy was begun.
We obtained anteroposterior and occipitomental (Water view) radiographs on all children in the study on the day of diagnosis. For children $6 years of age, we also obtained lateral views to permit assessment of the frontal and sphenoid sinuses (usually not well-developed in children <6 years of age). Sinus radiographs were independently reviewed, at the end of the study, by 2 reference radiologists (L.F., A.B.) who were unaware of any clinical data. Each sinus was rated as normal or abnormal. Although previous studies have classified children with >4 mm of mucosal thickening as having an abnormal radiograph consistent with a diagnosis of sinusitis. It is now clear that no degree of thickening is sufficient to rule in sinusitis. In addition, superimposition of ethmoidal air cells precludes reliable delineation of degree of mucosal thickening. Thus, instead of using the threshold of 4 mm (that was developed to rule in disease), we used the absence of any mucosal thickening to indicate absence of significant sinus disease (ie, children in whom all sinuses were found to be clear were considered as having a normal radiograph; all others were considered as abnormal). Disagreements between the 2 radiologists were resolved by discussion.
We used the Pediatric Rhinosinusitis Symptom scale (PRSS-P) score as the main measure of outcome. The PRSS-P asks parents to rate the severity of 8 symptoms (daytime cough, nighttime cough, runny nose, stuffy nose, irritability, green or yellow mucus from the nose, trouble sleeping, feeling tired) during the preceding 24 hours. Parents were asked to complete the scale every evening until the follow-up appointment (days [8] [9] [10] [11] [12] . Each symptom was scored on a 3-point Likert scale (none = 0, a little = 1, a lot = 2). The total score was obtained by summing the scores on these 8 equally weighted items. Completed diaries were collected at the time of the follow-up visit on days 8-12.
Statistical Analyses
We compared median time with resolution of symptoms (defined as reaching a score of #2 on the PRSS-P on 2 successive occasions) according to the levels of the potential prognostic factors (variables measured at baseline: signs, symptoms, nasopharyngeal culture results, and radiograph findings) using a proportional-hazards model. To assess the independent contributions of each factor, we formed a Cox multivariate model using variables significantly (P < .15) associated with the outcome on univariate analysis while adjusting for symptom score at the time of diagnosis. We also evaluated whether the type and/or dosage of antimicrobial used could have confounded our results.
Results
Of 258 children with a clinical diagnosis of acute sinusitis, 206 who were given antimicrobial therapy by their primary care providers and were considered for this analysis. Of these, 198 (96%) returned completed diaries. Demographic and clinical characteristics of these 198 children are shown in Table I . A total of 38 (19%) children, all of whom had worsening symptoms, had had symptoms for 6-9 days. A total of 106 (54%) children had symptoms for 10-19 days, and 54 (27%) had symptoms for 20-30 days. The mean age (SD) of children enrolled was 76.6 (35.3) months; 26 (14%) of 190 patients had normal radiographs. Most children (87%) were treated with either amoxicillin or amoxicillin/clavulanate; 43% of prescribed antibiotics were considered as high-dose (ie, $80 mg/kg/day amoxicillin).
Of the 150 children with nasopharyngeal cultures, 73 (49%) had at least one pathogen recovered. S pneumoniae, H influenzae, and M catarrhalis were isolated from 44 (29%), 23 (15%), and 22 (15%) children, respectively ( (5) were colonized with PCV7-related serotypes (23A or B). Betalactamase production was present in 48% and 100% of the H influenzae and M catarrhalis isolates, respectively. Younger children were significantly more likely to be colonized with S pneumoniae (40% of children <6 years vs 17% of children $6, P = .005). Colonization with H influenzae and M catarrhalis did not differ significantly by age.
Nasopharyngeal specimens were not collected in 48 children (mostly because of parental refusal). Parents in the suburban clinics were significantly more likely to refuse the nasopharyngeal swab than parents in the inner-city urban clinics. As such, children with missing cultures (who are not included in the study) were more likely to be white; there were no differences in age or sex between children with and without nasopharyngeal cultures.
The 11 variables that were significantly (P < .15; Table II ) associated with time to symptom resolution (severity of symptoms at enrollment, age at entry, growth of S pneumoniae, growth of M catarrhalis, history of allergic rhinitis, history of asthma or wheezing, headache, face pain, measured temperature >38 C, transverse nasal crease, and tenderness of either frontal sinus to pressure) on univariate analysis were considered for inclusion into the multivariate model. We did not include tenderness to pressure over the frontal sinuses in our multivariate model as it was assessed only for a subgroup of children (children $72 months of age), and thus was absent in more than one-half of the children. Neither the type of antimicrobial agent nor the dose used (high dose amoxicillin or amoxicillin/clavulanate vs all others) was associated with time to resolution (P = .74 and .62, respectively) and thus are not included in the multivariable models. The only variable that remained independently associated with time to resolution after adjustment for baseline severity of symptoms was nasopharyngeal colonization with S pneumoniae at baseline. Median time to symptom resolution in children with and without nasopharyngeal colonization with S pneumoniae was 6.5 and 8.5 days, respectively (P = .002; Figure) .
Discussion
In children with a clinical diagnosis of acute sinusitis who are being treated with antimicrobial therapy, those with proven nasopharyngeal colonization with S pneumoniae resolved more rapidly than children who were not colonized with S. pneumoniae. A difference of 2 days in the time to resolution of symptoms is clinically meaningful. The association between nasopharyngeal colonization with S pneumoniae and time to resolution of symptoms was robust; it remained significant after controlling for other potential confounding variables (ie, severity of symptoms at baseline and type and dosage of antimicrobial agent used). Because the nasopharynx is the reservoir from which pathogens enter the sinuses, it stands to reason that children with pathogens in their nasopharynx appear to benefit more from antimicrobial therapy. This hypothesis is consistent with randomized, placebo-controlled trials of adults with acute sinusitis or upper respiratory tract infection that have shown antimicrobial therapy to be more effective in the subset of patients with nasopharyngeal colonization with respiratory pathogens. 3, 5 Colonization with pathogens other than S pneumoniae did not independently predict response to therapy. The reasons for this remain unclear. Perhaps antimicrobial agents are less effective in children with H influenzae and M catarrhalis because these organisms are better able to produce biofilm. 6 Or, perhaps the host's immune response to infection caused by S pneumoniae is different from that caused by H influenzae and M catarrhalis. 7 Future work regarding the nasal microbiome may shed some light on this question.
The overall rate of nasopharyngeal colonization with respiratory pathogens observed in this study (48%) was consistent Amox, amoxicillin; Amox/clav, amoxicillin/clavulanate. *Mean and SD, not number of children, presented. †Pathogen alone or in combination with other pathogen(s). zVaccine-related serotypes include serotypes 9A, 19B, 23A, and 23B.
with rates from the only previous study that reported nasopharyngeal colonization data in children with acute sinusitis since the introduction of PCV7. 8 The proportion of penicillin-susceptible S pneumoniae isolates was similar in both studies. In contrast, we found relatively lower rates of colonization with H influenzae (15%). 8 This difference may be related to the different demographic and clinical characteristics of children enrolled in the 2 studies.
This study, conducted after introduction of PCV7, report the distribution of serotypes of S pneumoniae in the nasopharynx of children diagnosed with acute sinusitis. We found that 57% of S pneumoniae isolates were nonvaccine serotypes (serotypes not found in PCV-7 or PCV-13), a finding that is consistent with a previous study of nasopharyngeal colonization in children with acute otitis media conducted during the same time period in France. 9 In contrast with the French study, however, we found lower rates of colonization with serotype 19A (24% vs 9%). Selection for resistant serotypes, specifically serotype 19A, has been linked to high antibiotic pressure. 10 Compared with the French study, children in our study were older, less likely to be in daycare, and less likely to have received antibiotics recently. Accordingly, the observed differences in the proportion of children carrying serotype 19A are likely the result of differences in the demographic and clinical characteristics of the samples.
On the basis of our results, we recommend that authors of future randomized trials of children with acute sinusitis *Only variables felt to be important a priori or which were found to be significant are included in the Table. †Defined as exposure to 3 or more children for 10 or more hours per week at home, daycare or school.
zAs assessed by the examining physician on a 100 point visual analog scale (0 = not severe, 100 = severe). xIn 13 children, the dose was not recorded. {Median time to resolution could not be calculated because <50% of children had symptom resolution. kNot all 198 children provided data for these findings.
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Vol. -, No. -consider testing for respiratory pathogens (either through nasopharyngeal culture or by polymerase chain reaction testing) at the time of randomization. In this way, the efficacy of antimicrobials in these subgroups could be compared. If substantial differences in efficacy are found, perhaps point-of-care tests for S pneumoniae, 11,12 could serve as a method of reducing prescription of antimicrobials.
This study has several limitations. First, we did not obtain nasopharyngeal samples on all children enrolled. Although performance of the nasopharyngeal culture was related to the child's race, it is unlikely that it would have biased our results (because race was not associated with either colonization with S pneumoniae or with time to resolution of symptoms). Second, because this study was not placebocontrolled, our data cannot be used to make decisions about subgroups of children with acute sinusitis who should or should not be treated with antimicrobial therapy. Third, inclusion of children with atopic diatheses may have biased results. However, we tried to ensure that episodes of respiratory disease did not represent merely allergic rhinitis or an exacerbation of asthma by enrolling most children during the winter months, by excluding children with wheezing on examination, and by excluding children presenting with nocturnal cough as their sole symptom. Furthermore, the presence of atopic disease was not significantly associated with time-to-resolution of symptoms in the multivariate model. Finally, based on data collected after introduction of the PCV7, [13] [14] [15] [16] [17] we expect that with the introduction of the PCV13, the proportion of disease caused by S pneumoniae will decrease, by eliminating disease caused by serotypes included in the vaccine at least temporarily However, this reduction is likely to be modest because slightly more than one-half of S pneumoniae isolates were non-PCV13 serotypes. Accordingly, colonization with S pneumoniae will likely remain an important prognostic factor. n Figure. Resolution of symptoms in children with acute sinusitis according to nasopharyngeal colonization with S. pneumoniae at baseline.
